Jefferson Capital (JCAP) Price to Sales (2025 - 2026)
Jefferson Capital's (JCAP) quarterly Price to Sales came in at 6.3 in Q2 2026, up 1935.67% year-over-year from 0.31 in Q2 2025, and up 45.41% quarter-over-quarter from 4.33 in Q4 2025.
Powered by 
Analysis
Jefferson Capital (JCAP) Price to Sales (2025 - 2026) Analysis & Trends
Jefferson Capital (JCAP) has reported Price to Sales for 2 consecutive years, with 6.3 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Price to Sales rose 1935.67% year-over-year to 6.3 in Q2 2026; TTM through Jun 2026 was 1.76, a 1709.17% increase from a year earlier, with the FY2025 full-year figure at 1.09, changed N/A from the prior year.
- Price to Sales was 6.3 for Q2 2026 at Jefferson Capital, up from 4.33 in the prior quarter.
- Over five years, Price to Sales peaked at 6.67 in Q3 2025 and troughed at 0.31 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Orix | 44.91 Bn | 45.24 Bn | 4.68 Bn |
| 2 | Royalty Pharma | 36.78 Bn | 38.89 Bn | - |
| 3 | Royal Gold | 22.19 Bn | 22.06 Bn | 390.45 Mn |
| 4 | OR Royalties | 6.98 Bn | 6.91 Bn | 82.22 Mn |
| 5 | Encore Capital | 2.06 Bn | 1.88 Bn | 455.04 Mn |
| 6 | Atlanticus Holdings | 1.41 Bn | 853.17 Mn | 686.46 Mn |
| 7 | Jefferson Capital | 1.23 Bn | 1.21 Bn | - |
| 8 | Upbound | 1.11 Bn | 1.00 Bn | 594.84 Mn |
| 9 | Lufax Holding | 1.08 Bn | -1.19 Bn | - |
| 10 | Metalla Royalty & Streaming | 957.79 Mn | 946.72 Mn | 4.75 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.30 |
| Dec 31, 2025 | 4.33 |
| Sep 30, 2025 | 6.67 |
| Jun 30, 2025 | 0.31 |